1 Bousser MG, Ferro JM. Cerebral venous thrombosis:an

update[J]. Lancet Neurol, 2007, 6:162-170.

2 Ferro JM, Canhao P, Stam J, et al. Prognosis of

cerebral vein and dural sinus thrombosis:results of the

International Study on Cerebral Vein and Dural Sinus

Thrombosis (ISCVT)[J]. Stroke, 2004, 35:664-670.

3 Dentali F, Crowther M, Ageno W. Thrombophilic

abnormalities, oral contraceptives, and risk of cerebral vein thrombosis:a meta-analysis[J]. Blood, 2006,

107:2766-2773.

4 Gosk-Bierska I, Wysokinski W, Brown RD Jr, et al.

Cerebral venous sinus thrombosis:Incidence of venous

thrombosis recurrence and survival[J]. Neurology,

2006, 67:814-819.

5 Saposnik G, Barinagarrementeria F, Brown RD Jr,

et al. American Heart Association Stroke Council

and the Council on Epidemiology and Prevention.

Diagnosis and management of cerebral venous

thrombosis:a statement for healthcare professionals

from the American Heart Association/American

Stroke Association[J]. Stroke, 2011, 42:1158-1192.

6 Cundiff DK. Anticoagulants for cerebral venous

thrombosis:Harmful to patients?[J]. Stroke, 2014,

45:298-304.

7 Gulati D, Strbian D, Sundararajan S. Cerebral venous

thrombosis:Diagnosis and management[J]. Stroke,

2014, 45:e16-e18.